NSE / BSEHealthcare
β‚Ή766.75-2.10-0.27%
P/E87.7Mkt Capβ‚Ή24.92 K CrEV/EBITDA65.6

Krishna Institute of Medical Sciences Limited

P/E87.7Mkt Capβ‚Ή24.92 K CrEV/EBITDA65.6
Company Profile

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics. In addition, the company offers orthopedics, arthroscopic and spine surgery, and ortho rehabilitation; medical surgical and radiation, and BMT and hematology; ophthalmology; dermatology, cosmetology, and plastic and reconstructive surgery; and clinical infectious diseases. Further, it provides imaging and interventional radiology; paediatrics and pediatric sub specialities, and neonatology; maxillo-facial surgery; OT and day care anaesthesia and pain medicine; and pathology, microbiology, and biochemistry. Additionally, the company offers molecular biology and clinical hematology; internal medicine, general surgery, and diabetology and endocrinology; and ICU, CTICU, SICU, NICU, PICU, neuro and ECMO ICU, and post transplant ICU services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 15 Sept 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Strengths1

  • Operating margin of 30.0% exceeds Healthcare median (24.8%)

Concerns0

    Rule-based from financial data. Not advice.

    Price Historyβ–² 1.70% over 1Y

    Monthly Returns

    Unlock Monthly Returns

    Available on Pro and Institutional plans.

    Sign up free

    Year-to-Date ROI

    Unlock Year-to-Date ROI

    Available on Pro and Institutional plans.

    Sign up free

    Historical Volatility

    Unlock Historical Volatility

    Available on Pro and Institutional plans.

    Sign up free

    Historical Performance

    Revenue, profitability, and cash flow trends (β‚Ή Crores)

    Revenue (10Y)

    Operating Income (10Y)

    Net Profit (10Y)

    Operating Margin % (10Y)

    Dividend Payout % (10Y)

    Free Cash Flow (10Y)

    Growth Summary

    Latest fiscal year: Mar 2025

    Revenueβ‚Ή1.38 K Crβ–² 13.3%
    EBITDA Growthβ€”
    Net Profitβ‚Ή303.00 Crβ–² 28.9%
    Cash from Ops (CFO)β€”
    Free Cash Flow (FCF)β€”β–Ό 133.3%
    Revenue CAGR 5Y9.1%
    EBITDA CAGR 5Y12.5%
    Net Profit CAGR 5Y14.2%
    NP Growth 1Y28.9%

    Historical Growth

    Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

    YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
    Mar 2025β‚Ή1.38 K Crβ€”β‚Ή303.00 Crβ€”β€”14.0%13.3%28.9%
    Mar 2024β‚Ή1.22 K Crβ€”β‚Ή235.00 Crβ€”β€”12.6%8.0%-6.7%
    Mar 2023β‚Ή1.13 K Crβ€”β‚Ή252.00 Crβ€”β€”15.5%-1.0%-9.4%
    Mar 2022β‚Ή1.14 K Crβ€”β‚Ή278.00 Crβ€”β€”20.2%22.5%47.1%
    Mar 2021β‚Ή933.00 Crβ€”β‚Ή189.00 Crβ€”β€”20.8%18.1%56.2%
    Mar 2020β‚Ή790.00 Crβ€”β‚Ή121.00 Crβ€”β€”19.4%11.7%-375.0%
    Mar 2019β‚Ή707.00 Crβ€”β‚Ή-44.00β€”β€”-8.7%12.6%-45.7%
    Mar 2018β‚Ή628.00 Crβ€”β‚Ή-81.00β€”β€”40.7%17.2%-345.5%
    Mar 2017β‚Ή536.00 Crβ€”β‚Ή33.00 Crβ€”β€”10.2%10.5%37.5%
    Mar 2016β‚Ή485.00 Crβ€”β‚Ή24.00 Crβ€”β€”9.2%β€”β€”

    Financial Statements

    Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

    Free plan Β· showing 1 year of data.Upgrade

    Consolidated Figures in USD Millions.

    Unnamed: 0TTM
    Revenue / Net Sales1,497
    Total Expenses1,076
    EBIT / Operating Profit421
    OPM %28%
    Other Income80
    Finance Costs45
    Depreciation & Amortisation68
    Profit Before Tax388
    Tax %-
    Net Profit / PAT292
    EPS (β‚Ή)7.31
    Dividend Payout %-

    Peer Comparison

    Healthcare sector peers, ranked by market cap

    CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
    Krishna Institute of Medical Sciences Limitedthis co.β‚Ή24.92 K Crβ‚Ή1.38 K Cr87.7010.8965.5513.3%
    Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
    Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
    Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
    Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
    Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
    Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
    Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

    Learn while you research

    Hand-picked academy chapters to deepen your understanding of Krishna Institute of Medical Sciences Limited and the metrics that matter.

    Browse the full Equiscale Academy